Eugenodilol
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
|
1-(4-Allyl-2-methoxyphenoxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}-2-propanol
|
|
| Identifiers | |
| ATC code | None |
| PubChem | CID: 9930145 |
| ChemSpider | 8105776 |
| Chemical data | |
| Formula | C22H29NO5 |
| Molecular mass | 387.47 g/mol |
|
|
|
|
Eugenodilol is a beta blocker derived from eugenol.[1]
References[edit]
- ^ Huang YC, Wu BN, Lin YT, Chen SJ, Chiu CC, Cheng CJ, Chen IJ (Jul 1999). "Eugenodilol: a third-generation beta-adrenoceptor blocker, derived from eugenol, with alpha-adrenoceptor blocking and beta2-adrenoceptor agonist-associated vasorelaxant activities". J Cardiovasc Pharmacol 34 (1): 10–20. doi:10.1097/00005344-199907000-00003. PMID 10413061.
| This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |

